Diphenylpyraline Hydrochloride
Generic Name: diphenylpyraline hydrochloride
Manufactured by GLAXOSMITHKLINE. Dosage form: CAPSULE, EXTENDED RELEASE. Route: ORAL. Active ingredients: DIPHENYLPYRALINE HYDROCHLORIDE (5MG). Application: NDA011945.
Overview
Manufactured by GLAXOSMITHKLINE. Dosage form: CAPSULE, EXTENDED RELEASE. Route: ORAL. Active ingredients: DIPHENYLPYRALINE HYDROCHLORIDE (5MG). Application: NDA011945.
Dosage
Available as capsule, extended release for oral use.
Related Medications
Anticoagulant Citrate Phosphate Dextrose Adenine (cpda-1) Solution
anticoagulant citrate phosphate dextrose adenine (cpda-1) solution
Calculi Dissolution Agent [EPC]
Cardiospermum, Curcuma Longa
cardiospermum, curcuma longa
Purpose Anti-Fungal Anti-microbial
Mitoxantrone Hydrochloride
mitoxantrone hydrochloride
DESCRIPTION: Mitoxantrone Injection, USP (concentrate) is a synthetic antineoplastic anthracenedione for intravenous use. It is supplied as a concentrate that MUST BE DILUTED PRIOR TO INJECTION. The concentrate is a sterile, nonpyrogenic, dark blue aqueous solution containing mitoxantrone hydrochloride equivalent to 2 mg/mL mitoxantrone free base, with the following inactive ingredients: sodium chloride (0.800% w/v), sodium acetate (0.005% w/v), acetic acid (0.046% w/v), and water for injection.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.